Author: Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Korn WM, Leong S, Linn C, Lockhart AC, Ly QP, Mulcahy MF, Orringer MB, Perry KA, Poultsides GA, Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H
Year: 2016
AGREE II score: Available
Developer organization: National Comprehensive Cancer Network
Type of cancer: Gastrointestinal
Patient population: Adult
Location: International
This is a clinical practice guideline for gastric cancer. The guideline provides an evidence- and consensus-based treatment approach for the management of patients with gastric cancer. Topic areas discussed within the guideline include: staging, principles of pathology, surgery, endoscopic therapies, radiation therapy, combined modality therapy, chemotherapy, and follow-up.
AGREE II - Quality of Reporting Assessment:
Scope and purpose: 58.3%
Applicability: 45.8%
Stakeholder involvement: 55.6%
Editorial independence: 91.7%
Rigour: 65.6%
Clarity presentation: 69.4%
